Specialists’ prescribing of bDMARDs is being put under the spotlight by a new NPS MedicineWise-led program that aims to get the “best health and economic outcomes” for use of the expensive drugs. Rheumatologists and clinical immunologists are the first target of the Value in Prescribing bDMARDs Program which will see them sent reports on their ...
Rheumatologists’ bDMARDs prescribing the target of government-funded program
By Megan Howe
20 Oct 2020